CSA Medical Advances RejuvenAir System for Chronic Bronchitis Treatment with FDA Submission CSA Medical has submitted a Premarket Approval application for its RejuvenAir System, aimed at treating chronic bronchitis in COPD patients, marking a significant milestone.

CSA Medical Advances RejuvenAir System for Chronic Bronchitis Treatment with FDA Submission #USA #Boston #Chronic_Bronchitis #RejuvenAir #CSA_Medical